Kinetic of T cell reactivity and antibody responses to SARS-CoV-2 after different rounds of vaccination in persons with multiple sclerosis treated with ocrelizumab

Authors
Category Primary study
ConferenceMSmilan2023
Year 2023
This article has no abstract
Epistemonikos ID: 53e74010fc3e68c6489a7e4fa267b8e8fe467169
First added on: Jan 07, 2026